Search

Copyright of Ege Journal of Medicine is the property of Ege University, Faculty of Medicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Pediatric Disease / Türkiye Çocuk Hastalıkları Dergisi is the property of Turkish Journal of Pediatric Disease and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Pediatric Disease / Türkiye Çocuk Hastalıkları Dergisi is the property of Turkish Journal of Pediatric Disease and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: Hematopoietic stem cell transplantation is recommended as a first-line treatment in a pediatric severe aplastic anemia, if the patient has an HLA-matched family donor. In this study, we aimed to evaluate the allogeneic hematopoietic stem cell transplantation outcomes of our patients who were followed with a diagnosis of aplastic anemia. Material and Methods: From April 2010 to July 2017, 10 pediatric acquired aplastic anemia patients treated with allogeneic hematopoietic stem cell transplantation at our center were evaluated retrospectively from patient charts and computer records. Results: A total of 12 allogeneic stem cell transplantations had been performed in 10 patients with severe and very severe acquired aplastic anemia. Mean age during transplantation was 10.9±3.76 (min=4.6-max=16.1) years and 80% of the patients were female. Mean interval from diagnosis to transplantation was 10.1±7.65 (min=3-max=31) months and all of the donors were siblings. The mean nucleated cell count was 4.69±2.17x108 (min=1.13x108-max=8.43x108) and CD34+ cell count was 3.25±1.39x106 (min=1.65x106-max=6.55x106). Mean neutrophil engraftment time was 16.2±0.8 (min=15-max=17) days and platelet engraftment time was 26±6.5 (min=16-max=37) days. Acute graft versus host disease was not observed in any patient and limited chronic pulmonary graft versus host disease was seen in only one patient. Primary graft failure developed in one patient and secondary graft failure in another patient. None of the patients developed myelodysplastic syndrome (MDS), leukemia, paroxysmal nocturnal hemoglobinuria (PNH) or secondary malignancy during follow-up. One patient died due to intracranial hemorrhage on day +16 after transplantation. Mixed chimerism was present in 66.7% and all patients are now followed up with complete hematological remission. Conclusion: We achieved 90% overall survival in our patients over a 7-year follow-up period. Considering the high rates of relapse and clonal hematopoiesis after immünosuppressive treatment in studies reported in the literature, we believe that allogeneic hematopoietic stem cell transplantation can be used as a first-line treatment in children with aplastic anemia, especially if there is an HLA-compatible family donor. [ABSTRACT FROM AUTHOR]

Copyright of Journal of Pediatric Disease / Türkiye Çocuk Hastalıkları Dergisi is the property of Turkish Journal of Pediatric Disease and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Pediatric Disease / Türkiye Çocuk Hastalıkları Dergisi is the property of Turkish Journal of Pediatric Disease and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)